New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 22, 2012
09:46 EDTTXRH, FIRE, CHS, MDCO, CYH, AUBN, WIRE, GRMN, CLHGappers report: Bullish gaps
This is a list of stocks making unusual moves on the open versus the prior day close. Gapping stocks often have excessive movements during the day and in the days thereafter. We use 5% for filter criteria and scanned for stocks that traded above $10 the prior day. GAPPING UP: WIRE 5.13%, CLH 5.26%, AUBN 5.57%, MDCO 8.11%, TXRH 9.26%, GRMN 9.71%, CYH 11.67%, CHS 13.35%, FIRE 17.09%.
News For AUBN;CHS;CLH;CYH;FIRE;GRMN;MDCO;TXRH;WIRE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
10:17 EDTCLHOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:47 EDTCLHClean Harbors initiated with a Neutral at Macquarie
Target $46.
December 18, 2014
14:32 EDTCLHClean Harbors: Safety-Kleen business revises pay-for-oil structure
Subscribe for More Information
12:06 EDTCYHObamacare concerns seen creating good entry point for hospital stocks
Subscribe for More Information
09:06 EDTCYHHospital stocks have reached nice entry point, says Sterne Agee
Subscribe for More Information
07:01 EDTMDCOThe Medicines Co., SciClone establish strategic partnership
The Medicines Company (MDCO) and SciClone Pharmaceuticals (SCLN) announced the establishment of a strategic partnership for two cardiovascular products in China. The partnership includes an agreement granting SciClone a license and the exclusive rights in China to promote two products of The Medicines Company: ANGIOMAX for Injection, an anticoagulant indicated in patients undergoing percutaneous coronary intervention with provisional use of glycoprotein IIb/IIIa inhibitor and in patients with, or at risk of, heparin-induced thrombocytopenia and thrombosis syndrome undergoing PCI. A Phase 3 registration trial was completed in China and is currently under review by the China Food and Drug Administration for marketing approval. CLEVIPREX Injectable Emulsion, a third-generation dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or desirable. The clinical trial application for China was filed in 2013. Under the terms of the agreement, SciClone will be responsible for all aspects of commercialization, including pre- and post-launch activities, for both products in the China market excluding Hong Kong and Macau. SciClone has also agreed to assist in the China registration process for both products. Financial terms of the agreement, in addition to net sales royalties payable to The Medicines Company, include the following additional payments to The Medicines Company: an upfront payment; a product support services fee; and regulatory/commercial success milestone payments of up to an aggregate of $50.5M.
06:41 EDTCYHCommunity Health initiated with a Buy at Sterne Agee
Subscribe for More Information
December 17, 2014
10:51 EDTCYHLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Gupte provides outlook and favorite names for 2015 in the Hospitals and Managed Care Industry on an Analyst/Industry conference call to be held on December 18 at 1 pm.
December 16, 2014
15:01 EDTCYHJudge says Obama's immigration orders unconstitutional, Politico says
Subscribe for More Information
December 12, 2014
13:52 EDTCYHLeerink healthcare services analyst holds an analyst/industry conference call
Subscribe for More Information
December 11, 2014
08:02 EDTMDCOAlnylam, The Medicines Co. announce initiation of Phase 1 ALN-PCSsc trial
Subscribe for More Information
08:00 EDTCYHCommunity Health to divest Newport, Arkansas hospital
Community Health Systems announced that subsidiaries of the company have executed a definitive agreement to sell substantially all of the assets of 133-bed Harris Hospital in Newport, Arkansas, along with related outpatient services, to White County Medical Center of Searcy, Arkansas. The divestiture is expected to close early in the first quarter of 2015, subject to customary regulatory approvals and closing conditions. The company does not expect the divestiture to have a meaningful impact on financial operations. Following the divestiture of Harris Hospital, Community Health Systems affiliates will continue to operate nine hospitals in Arkansas.
December 8, 2014
12:25 EDTMDCOAntibiotic makers rise after Merck agrees to buy Cubist
Subscribe for More Information
10:11 EDTMDCOHigh option volume stocks
Subscribe for More Information
08:22 EDTCYHCommunity Health management to meet with Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use